Pharming Group (PHAR) PT Lowered to $40 at Oppenheimer
Tweet
Share
E-mailGet Alerts PHAR Hot Sheet
Price: $11.85 +1.46%
Rating Summary:
2 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
2 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Oppenheimer lowered its price target on Pharming Group (NASDAQ: PHAR) to $40.00 (from $41.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Stella International Holdings (1836:HK) (SLNLF) PT Lowered to HK$10 at Macquarie
- China Resources Beer Holdings Co Ltd. (291:HK) (CRHKY) PT Lowered to HK$31 at Macquarie
- Beike (BEKE) PT Raised to $23 at Morgan Stanley
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
